Why the study?
Does steroid treatment improve cardiac dimension and function in a patient with HIV-associated autoimmune myocarditis?
Does steroid treatment improve cardiac dimension and function in a patient with HIV-associated autoimmune myocarditis?
Auto-reactive myocarditis should be considered in HIV-associated dilated cardiomyopathy, as biopsy-guided steroid therapy may lead to complete resolution of cardiac disease.
Answers are grounded in this paper and cite their sources.
May support biopsy-guided steroids in select HIV myocarditis cases; hypothesis-generating and requires prospective confirmation.
BACKGROUND: Dilated cardiomyopathy occurring in HIV-infected patients raises both diagnostic and therapeutic challenging problems. Indeed myocardial involvement in HIV infection has been variously attributed to several causes, including viral, toxic, nutritional and autoimmune, but no specific treatment capable to substantially improve patients' prognosis has been recognized so far. CASE PRESENTATION: Hereby we describe the case of an autoimmune myocarditis manifesting with heart failure in a3 9-year-old man with HIV infection. Left ventricular endomyocardial biopsy showed a lymphocytic myocarditis characterized by over-expression of HLA-DR and negative polymerase chain reaction for cardiotropic viruses. Steroid treatment was followed by recovery of cardiac dimension and function. CONCLUSION: Presence of auto-reactive myocarditis should be considered in patients with HIV-associated dilated cardiomyopathy. Its recognition by endomyocardial biopsy followed by steroid administration may result in a complete resolution of cardiac disease.
No takes yet. Share an insight, caveat, or question.
Frustaci et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: